Clinical Study
Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
Figure 3
Kaplan-Meier analysis of progression-free survival (months): median progression-free survival was 11.0 months ( CI: 8.0–16.5).